A veteran New York-based financial leader and investment professional, Jay Zises serves as chairman of A Cap Investment Management. Focused on providing capital for young and emerging enterprises, Jay Zises keeps up with the latest innovations in a number of fast-growing businesses, such as synthetic biology. Short DNA segments that are man-made, synthetic oligos are used in many synthetic biology procedures. They typically serve as templates in these applications. An example of such application of synthetic oligos is in the polymerase chain reaction (PCR) process which is used to create thousands of copies of DNA from a very small sample for forensic and industrial applications. By 2028, the synthetic oligos market is expected to reach a cumulative annual growth rate of 22.8 percent according to Biospace.com. One of the major reasons why synthetic oligos are receiving more application is the fact that it fosters access to the artificial genetic material of desirable qualities, used in modern laboratories.